Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY: Despite the outcome of the hormone-replacement therapy trials, recent work has confirmed the putative antiatherogenic effects of hormone-replacement therapy on lipoprotein metabolism. Metabolic differences of route of administration of estrogen, particularly on haemostatic variables, may explain this clinical paradox, which continues to be an important research area.
|
Authors | Mary Seed, Robert H Knopp |
Journal | Current opinion in lipidology
(Curr Opin Lipidol)
Vol. 15
Issue 4
Pg. 459-67
(Aug 2004)
ISSN: 0957-9672 [Print] England |
PMID | 15243220
(Publication Type: Journal Article, Review)
|
Chemical References |
- Estrogens
- Lipoproteins
- Placebos
|
Topics |
- Arteries
(pathology)
- Cardiovascular Diseases
(etiology, genetics, metabolism)
- Clinical Trials as Topic
- Estrogens
(metabolism)
- Female
- Hormone Replacement Therapy
(adverse effects)
- Humans
- Lipid Metabolism
- Lipoproteins
(metabolism)
- Menopause
- Placebos
- Postmenopause
- Risk Factors
|